Example：10.1021/acsami.1c06204 or Chem. Rev., 2007, 107, 2411-2502
Potential of Microneedle Systems for COVID-19 Vaccination: Current Trends and Challenges Pharmaceutics (IF6.321), Pub Date : 2022-05-16, DOI: 10.3390/pharmaceutics14051066 Jasmin Hassan, Charlotte Haigh, Tanvir Ahmed, Md. Jasim Uddin, Diganta B. Das
To prevent the coronavirus disease 2019 (COVID-19) pandemic and aid restoration to prepandemic normality, global mass vaccination is urgently needed. Inducing herd immunity through mass vaccination has proven to be a highly effective strategy for preventing the spread of many infectious diseases, which protects the most vulnerable population groups that are unable to develop immunity, such as people with immunodeficiencies or weakened immune systems due to underlying medical or debilitating conditions. In achieving global outreach, the maintenance of the vaccine potency, transportation, and needle waste generation become major issues. Moreover, needle phobia and vaccine hesitancy act as hurdles to successful mass vaccination. The use of dissolvable microneedles for COVID-19 vaccination could act as a major paradigm shift in attaining the desired goal to vaccinate billions in the shortest time possible. In addressing these points, we discuss the potential of the use of dissolvable microneedles for COVID-19 vaccination based on the current literature.